LMKC
IDXX icon

L.M. Kohn & Company’s Idexx Laboratories IDXX Stock Holding History

L.M. Kohn & Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-416
Closed -$203K – 299
2024
Q2 		$203K Hold
416
– – 0.05% 253
2024
Q1 		$225K Hold
416
– – 0.06% 236
2023
Q4 		$231K Buy
+416
New +$195K 0.07% 209
2023
Q3 		– Sell
-416
Closed -$209K – 246
2023
Q2 		$209K Hold
416
– – 0.08% 213
2023
Q1 		$208K Sell
416
-297
-42% -$142K 0.09% 198
2022
Q4 		$292K Sell
713
-3
-0.4% -$1.17K 0.14% 160
2022
Q3 		$234K Hold
716
– – 0.11% 173
2022
Q2 		$252K Hold
716
– – 0.12% 184
2022
Q1 		$392K Buy
+716
New +$377K 0.15% 160

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

L.M. Kohn & Company's IDXX Position: Q3 2024 in Review

L.M. Kohn & Company sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 416 shares — an estimated $203K sold.

L.M. Kohn & Company first reported a position in IDXX in Q1 2022 and held it in 9 quarters. The position peaked at $392K in Q1 2022. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • L.M. Kohn & Company reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • L.M. Kohn & Company sold 416 Idexx Laboratories shares in Q3 2024, an estimated $203K.
  • L.M. Kohn & Company first reported a position in Idexx Laboratories in Q1 2022 and held it in 9 quarters.
  • L.M. Kohn & Company's Idexx Laboratories position peaked at $392K in Q1 2022.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on L.M. Kohn & Company's 13F filing for Q3 2024, filed 14 Nov 2024.